Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jun 28;4(6):241-6.
doi: 10.4329/wjr.v4.i6.241.

Epidemiology of prostate cancer and treatment remarks

Stefano Arcangeli  1 , Valentina Pinzi, Giorgio Arcangeli
Affiliations

Epidemiology of prostate cancer and treatment remarks

Stefano Arcangeli et al. World J Radiol. .

Abstract

Prostate cancer is one of the most common types of cancer and one of the leading causes of cancer death among men in the Western countries. The aim of the present analysis is to assess the cancer burden in order to ensure accurate strategies for chemoprevention and treatment, including the major therapeutic approaches for localized high-risk disease - surgery and radiation therapy - and quality of life issues related to each option.

Keywords: Chemoprevention; Epidemiology; Prostate cancer; Radiotherapy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Freedom from Biochemical Failure for patients treated with radical prostatectomy or external beam radiotherapy using Phoenix definition and 3 consecutive PSA increases > 0.2 ng/mL definition. FFBF: Freedom from Biochemical Failure; EBRT: External beam radiotherapy; RP: Radical prostatectomy.
Figure 2
Figure 2
Freedom from Biochemical Failure for patients treated with external beam radiotherapy, radical prostatectomy only and radical prostatectomy plus adjuvant treatment (external beam radiotherapy ± androgen deprivation therapy). FFBF: Freedom from Biochemical Failure; EBRT: External beam radiotherapy; RPo: Radical prostatectomy only; RP: Radical prostatectomy; AT: Adjuvant treatment.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71–96. - PubMed
    1. Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer. 2010;46:765–781. - PubMed
    1. Guileyardo JM, Johnson WD, Welsh RA, Akazaki K, Correa P. Prevalence of latent prostate carcinoma in two U.S. populations. J Natl Cancer Inst. 1980;65:311–316. - PubMed
    1. Billis A. Latent carcinoma and atypical lesions of prostate. An autopsy study. Urology. 1986;28:324–329. - PubMed
    1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1999. CA Cancer J Clin. 1999;49:8–31, 1. - PubMed